Myelogenous Leukemia, Chronic, Chronic Phase
3 clinical trials · Condition
◉ Watch Myelogenous Leukemia, Chronic, Chronic Phase
| Record | Firm | Date |
|---|---|---|
| Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial (NCT01887561) | Kanto CML Study Group | 2012-11-01 |
| Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan (NCT01464411) | Kanto CML Study Group | 2011-07-01 |
| Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C (NCT00038649) | M.D. Anderson Cancer Center | 2001-06-01 |
Track Myelogenous Leukemia, Chronic, Chronic Phase automatically
Every clearance here is in the API, with alerts when new ones post.